These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4980041)

  • 1. [Clostridium botulinum F. IV. Obtaining rabbit botulin antiserum].
    Mikhaĭlova IM
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Nov; 43(11):56-62. PubMed ID: 4980041
    [No Abstract]   [Full Text] [Related]  

  • 2. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on botulin antigens and antisera using methods of zone electrophoresis and agar diffusion precipitation].
    GENDON IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Feb; 29(2):95-100. PubMed ID: 13570409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation of purified, sorbed type F botulin toxoid. IV. Immunogenic and antigenic properties of purified, sorbed type F botulin toxoid].
    Tsarapkin VP; Mel'nikov VN; Khamzina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):131-2. PubMed ID: 4450868
    [No Abstract]   [Full Text] [Related]  

  • 5. [On obtaining antibodies to kidney tissue antigens].
    Andreeva NG
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Jun; 44(6):119-23. PubMed ID: 4978635
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production, biological assays and agar immunodiffusion study of rabbit immune serums with antierythropoietic activity].
    Peschle C; Semprini A; Tallarida G; Parrinello A; Sasso G; Condorelli M
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1792-5. PubMed ID: 4971944
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies of type F Clostridium botulinum. IV. Serological properties of soluble and insoluble antigens].
    Rymkiewicz D
    Med Dosw Mikrobiol; 1970; 22(1):13-20. PubMed ID: 4986009
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoproteomics Approach for Screening of Vaccine Candidates against Intestinal Botulism.
    Sharma A; Rani S; Alam SI; Ponmariappan S
    Protein Pept Lett; 2017; 24(8):771-780. PubMed ID: 28393685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
    Khouri JM; Motter RN; Arnon SS
    Vaccine; 2018 Apr; 36(15):2041-2048. PubMed ID: 29475762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigenic structure of Cl. botulinum types E and F].
    Bulatova TI; Perova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Apr; 47(4):28-32. PubMed ID: 4920529
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of Cross Reactive Antigens of C. botulinum Types A, B, E & F by Immunoproteomic Approach.
    Sharma A; Ponmariappan S; Sarita R; Alam SI; Kamboj DV; Shukla S
    Curr Microbiol; 2018 May; 75(5):531-540. PubMed ID: 29332140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the flocculation reaction for determining the titer of type B botulism antisera].
    Preger SM; Al'bitskaia NB
    Lab Delo; 1973; 3():188-9. PubMed ID: 4129128
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.
    Moreira C; da Cunha CE; Moreira GM; Mendonça M; Salvarani FM; Moreira ÂN; Conceição FR
    Anaerobe; 2016 Aug; 40():58-62. PubMed ID: 27236078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DETECTION OF BOTULISM TOXINS AND MICROBES OF B AND C TYPES IN THE BODIES OF SICK HUMAN AND ANIMAL SUBJECTS AND IN CADAVERS].
    SERGEEVA TI
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jul; 40():77-82. PubMed ID: 14070208
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
    Yu YZ; Zhang SM; Ma Y; Zhu HQ; Wang WB; Du Y; Zhou XW; Wang RL; Wang S; Yu WY; Huang PT; Sun ZW
    Clin Immunol; 2010 Nov; 137(2):271-80. PubMed ID: 20696619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obtaining and properties of antiserum to actomyosin-like contractile protein of thrombocytes - thrombosthenin].
    Odesskaia TA
    Lab Delo; 1976; (1):21-4. PubMed ID: 56482
    [No Abstract]   [Full Text] [Related]  

  • 18. NEUTRALIZATION OF THE BIOLOGICAL ACTIVITY OF ERYTHROPOIETIN BY IMMUNE SERA.
    LANGE RD; GARDNER E; WRIGHT CS; GALLAGHER NI
    Br J Haematol; 1964 Jan; 10():69-74. PubMed ID: 14115593
    [No Abstract]   [Full Text] [Related]  

  • 19. [Production in horses of bi and polyvalent anti-botulin sera A, B, C, E. II].
    KOROLEVA GA; MATVEEV KI; VOLKOVA ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1958 May; 29(5):83-7. PubMed ID: 13570514
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural resistance of irradiated animals to botulin toxins.
    Bulatova TI; Kaulen DR
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(1):67-73. PubMed ID: 5332086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.